KFDA to ban sales of sulpyrin and terfenadine

Published: 2004-11-05 07:00:00

Updated: 2004-11-05 07:00:00

The Korea Food and Drug Administration is considering taking administrative measures to ban the production and sales of sulpyrin and terfenadine due to possible side effects, as a result of its review on four substances such as sulpyrin, pemoline, terfenadine, and nandrolone.

The KFDA' move came after it was under fire for its slack control in August over cold drugs containing phenylpropanol...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.